Event Schedule
Have a look at Schedule
8:00
Bright Start
Registration & Breakfast with Impactful Investors
8:40
Welcome Remarks from World BI
Prabhnihal Singh Josan
Head of UK Office, World BI
8:45
Chair Welcome Address
Leo Kirkovsky
Senior Director, Exelixis
Innovations in Small Molecule Therapeutics
8:50
Insightful Opening Keynote
Botanical Drugs for Cancer Therapeutics Using Small Molecules
Igor Nasonkin
Founder, CEO & Chief Scientific Officer, Phythera Therapeutics, Inc
9:10
Talk 1
Biopharmaceutics Tools in Early Drug Product Development
Siddharth (Sid) Kesharwani
Small Molecule CMC Development, Abbvie
9:30
Partner Slot 1
Leveraging Large-scale Genetics and Machine Learning: From Target Discovery to Population Stratification
Vincent Plagnol
Chief Scientific Officer, Genomics
9:50
Talk 2
Developing Scalable and Cost-Effective Gene Therapies to Reduce Patient Cost, and Enhance Global Outreach
Pranav Mathur
Senior Director, Cirsium Biosciences
10:10
Coffee Break & Networking Session
Emerging Modalities in Drug Discovery
11:00
Talk 3
Non-Degrading Molecular Glues
Rick Ewing
VP, Head of Chemistry, Rapafusyn Research and Development
11:20
Partner Slot 2
TBC
Joe Lackey
Technical Manager, LGC Standards
11:30
Talk 4
Advances in Small Molecule Proximity-Induced Medicines: Targeting Disease Through Molecular Interactions
Alexandra Joseph
Chief Scientific Officer, Photys Therapeutics
11:50
Pitch Deck Sessions
12:00
Talk 5
Pre-Eclampsia and Hypertension: Do We Have the Right Targets?
Michael N. Liebman
Managing Director, Co-Founder, IPQ Analytics, LLC
12:20
Speed Networking
12:30
Interactive Panel Discussion
From Start to Scale: Navigating Successful Exits in Drug Discovery Startups
Moderator
Carolina Garcia Rizo
Board Member, Oisin bio
Panellists
Phillip Ebner
Executive Director - Life Sciences, JPMorgan Chase & Co.
Ed Addison
Executive Chairman, Cloud Pharmaceuticals, Inc.
Philip M Arlen
CEO and Founder, Precision Biologics
13:00
Lead Generation Luncheon
From Data to Drugs: LIGHT, CAMERA, AI in Action
14:00
Keynote Presentation
Unlocking the Power of AI in Drug Discovery for Rare Diseases: From Digital Twins to Personalized Medicine
Amir Lahav
Founder & CEO, SkyMedAI
14:20
Featured Presentation
ML, AI, and GPT in Drug Discovery
Istvan Enyedy
Senior Director Computational Chemistry, Third Harmonic Bio
14:40
Partner Slot 3
TBC
Jędrzej Świeżewski
Head of AI, Appsilon
14:50
Talk 6
Combining AI, Quantum Computing and HPC for Advancing Pharmacology and Clinical Trials
Zoran Krunic
Senior Manager of Data Science, Amgen
15:10
Pose for Discovery: A 10-Minute Interactive Snap Challenge
(Attendees strike their best innovation pose and share on social media. The most-liked photo wins a surprise gift!)
15:20
Coffee Break & Networking Session
15:50
Talk 7
From Tools to Partners: The Evolving Role of AI in Drug Discovery
Nicholas Wisniewski
Vice President, Head of Bioinformatics and Data Science, Stemson Therapeutics
16:10
Breakthrough Talk
AI-Powered Patient-Derived Midbrain Organoid Platform for Precision Drug Discovery in Parkinson’s Disease
Dr. Jun Yin
CTO, BrainStorm Therapeutics
Medicinal Chemistry
16:30
Keynote Presentation
Mixing and Matching Payloads and Linkers for Optimal Efficacy
Thomas Nittoli
Senior Director, Regeneron Pharmaceuticals
16:50
Talk 8
MolecuLern: A Data Deep Learning Fragment Assisted Platform for the Drug Discovery and Development of Orally Available Small Molecules
Hariprasad Vankayalapati, M. Pharm., PhD
Chief Scientific Officer, Biolexis Therapeutics, Inc.
17:10
Talk 9
Next-Generation DNA-Encoded Libraries: Revolutionizing Hit Generation and Lead Optimization
Patrick Neal
Cheminformatics Analyst, Gsk
17:30
Chair Closing Remarks
Leo Kirkovsky
Senior Director, Exelixis
17:40
Happy Hour Networking
8:00
Bright Start
Registration & Breakfast with Impactful Investors
8:40
Welcome Remarks from World BI
Prabhnihal Singh Josan
Head of UK Office, World BI
8:45
Chair Welcome Address
Leo Kirkovsky
Senior Director, Exelixis
9:00
Keynote Presentation
Translating Research into Action: The Role of Strategic Partnerships in Pharma Innovation
Tari Suprapto
Director, Search & Evaluation, Novo Nordisk
Beyond Algorithum: AI Driven Drug Discovery
9:20
Talk 10
Application of AI to All Phases of Drug discovery and Development
Ed Addison
Executive Chairman, Cloud Pharmaceuticals, Inc.
9:40
Talk 11
Gen AI in Drug Development
Monica Jain
Director, R&D Data Science, Johnson & Johnson Innovative Medicine
10:00
Talk 12
Real-World Studies in AI-Driven Drug Discovery and Development
Petrina Kamya, Ph.D.
Global Head of AI Platforms, VP, Insilico Medicine
10:20
Coffee Break & Networking Session
Advancing Longevity
11:10
Keynote Presentation
AI and Aging Vaccines
Dr. Ronjon Nag, CEng, FIET
Founder & Managing Director, R42 Group
Adjunct Professor in Genetics, Stanford School of Medicine
11:30
Talk 13
Reversing Brain Aging to Prevent Dementia
Christin Glorioso, MD PHD
CEO & Co-founder, NeuroAge Therapeutics
11:50
Speed Networking
12:00
Insightful Talk
Leveraging Aging-Induced Microgravity for Drug Discovery
David Furman
Director and Associate Professor, Buck Institute for Research on Aging
Bridging Innovation and Investment
12:20
Fish Bowl Investor-Startups Panel
The Emerging Technologies in Harnessing AI for Accelerated Drug Discovery: From Target Identification to Precision Medicine
Moderator
Jack Florio
Founder and Managing Director / Partner, IPL Capital Advisory / Deallus Consulting
Panellists
Tayo Sanders
Scientist & Founder | Biotech Investor | Rhodes Scholar, Arrowpoint Labs
Abishek Kulshreshtha
Partner, Co-Founder, Arrowpoint Labs
13:00
Lead Generation Luncheon
Therapeutic Areas Breakthroughs; From Traditional to Advance
14:00
Featured Traditional
The Naturopathic Treatment of Cancer and Chronic Diseases with Immunotherapy via Immunomodulation
Eric Scheinbart M.D.
MD, Immunity Redefined LLC
14:20
Talk 14
Immunotherapy Breakthroughs In Oncology
Dayson Moreira
Senior Scientist, Appia Bio
14:40
Talk 15
Novel Therapeutics in Protein Engineering for Immuno-Oncology
Mark Burk
Founder, President and CEO, Lassogen, Inc.
15:00
Coffee Break & Networking Session
Advancements in Biologics and Therapeutic Antibodies
15:30
Keynote Presentation
Innovating Against Inflammation: A New Frontier in Chronic Disease Therapeutics
Dr. David J. Bearss
Chief Executive Officer (CEO), Halia Therapeutics
15:50
Featured Presentation
The Development of Monoclonal Antibodies Targeting Cancer
Philip M Arlen
CEO and Founder, Precision Biologics
16:10
Talk 16
Using SMS Cells to Overcome the Many Bottlenecks of Regenerative Cell Therapy
Abdulkader Rahmo
President & CSO, SMSbiotech
16:30
Talk 17
Next-Generation Antibody-Drug Conjugates (ADCs)
Brian A. Mendelsohn
Executive Director, Discovery Biotherapeutics, Exelixis
16:50
Pose for Discovery Winner Announcement
(The most creative innovation pose wins! Announcement & prize distribution.)
17:00
Chair Closing Remarks
Leo Kirkovsky
Senior Director, Exelixis
Thank You!
Your details have been successfully submitted 😍